Founded in 2004, CIDP – a QIMA Life Sciences company is a full-service international Contract Research Organization (CRO) delivering specialized research, testing, and scientific support services to the pharmaceutical, cosmetic, medical device, and nutraceutical industries. Originally established as Centre International de Développement Pharmaceutique, CIDP has built a strong reputation for excellence in preclinical evaluation clinical research, medical and scientific writing, and regulatory support.
With operations across Mauritius, Brazil, India, and Romania, CIDP provides end-to-end support throughout the product development lifecycle, from early-stage research to clinical studies, data management, biostatistics, scientific and medical writing and regulatory affairs.
Backed by multidisciplinary scientific expertise, dedicated clinical facilities, and access to diverse multi-ethnic volunteer panels, CIDP conducts high-quality studies designed to demonstrate product safety, efficacy, and performance while ensuring compliance with international regulatory standards. Through its commitment to scientific rigor and innovation, CIDP helps clients accelerate product development and confidently bring new solutions to global markets.
CIDP provides integrated research, testing and scientific support services across life sciences sectors.
Services include:
Pre-clinical research (in vitro and ex vivo) including skin penetration testing
Clinical research (invivo, safety, efficacy, make-up, hair care, longevity, efficacy with GLP-1 analogues, photobiology studies)
Industries served include:
Cosmetics and personal care
Pharmaceuticals and biotechnology
Medical devices
Nutraceuticals and wellness products
CIDP is recognized for its integrated CRO model combining preclinical, clinical, data management, biostatistics and regulatory expertise within a single organization. Its international footprint and access to diverse volunteer populations enable the design of multi-centric and multi-ethnic studies aligned with evolving global market requirements.
The company combines scientific rigor, operational flexibility and advanced laboratory and clinical infrastructure to support robust data generation across cosmetic and pharmaceutical development programmes. Clients value CIDP’s collaborative approach, tailored study designs and commitment to innovation, quality and regulatory compliance.
CIDP is certified to ISO 9001:2015 and ISO/IEC 27001, and has also been awarded the EcoVadis Silver Medal in recognition of its sustainability performance. Clinical activities are conducted in accordance with Good Clinical Practice (ICH-GCP) and the ethical principles of the Declaration of Helsinki for research involving human subjects.
CIDP employs validated laboratory and clinical systems, including FDA 21 CFR Part 11-compliant platforms. Its expertise is further supported by CIR accreditation and participation in AFNOR and BIPEA photobiology programs, reinforcing the reliability and regulatory acceptance of its scientific data.
As part of QIMA Life Sciences, CIDP strengthens QIMA’s global CRO capabilities across clinical research, cosmetic testing and pharmaceutical development. Its expertise expands QIMA Life Sciences’ international scientific network, supporting integrated research, testing and regulatory solutions across the life sciences sector.
Contact our team to learn more about CIDP’s clinical and preclinical research services and their role within QIMA Life Sciences.